Clinical Trials Directory

Trials / Completed

CompletedNCT01391624

Study on the Possible Effects of Diet Supplementation With Essential Fatty Acids in Chocolate Craving Volunteers

Status
Completed
Phase
Phase 2 / Phase 3
Study type
Interventional
Enrollment
30 (actual)
Sponsor
Federal University of São Paulo · Academic / Other
Sex
All
Age
18 Years – 45 Years
Healthy volunteers
Accepted

Summary

The purpose of this study is to determine whether essential polyunsaturated acids (omega 3) are capable of reducing chocolate craving symptoms in healthy patients. Our hypothesis is that the omega 3 fatty acids have properties which stabilize and normalize neuronal functioning in many conditions, including chocolate craving.

Detailed description

Polyunsaturated fatty acids (of the omega 3 subtype) are fundamental in human diet, as they are components of cellular membranes, guaranteeing their fluidity and their functions of separating intracellular and extracellular means and transporting several substances to and from cellular microenvironment. Modern theories profess that lack of omega 3 fatty acids in western diets may be the cause of several deletery changes in neuronal physiology, which may cause or make worse several pathological conditions, such as depression, mood instability, and drug craving. The role of serotonin as the main lacking component in the conditions is well documented, and it is thought that omega 3 is important in the synthesis, transportation, and ultimately the activity of this neurotransmitter. Out theory states that supplementation with these acids can restore normal neuron balance, improving the condition of chocolate craving patients.

Conditions

Interventions

TypeNameDescription
DRUGFlaxseed oil3 g (3 capsules/day) of flax oil for a period of 8 weeks
DRUGParaffin + # 2 dye3 capsules of mineral oil (ineffective) for 8 weeks.

Timeline

Start date
2010-08-01
Primary completion
2011-01-01
Completion
2011-01-01
First posted
2011-07-12
Last updated
2011-07-12

Locations

1 site across 1 country: Brazil

Source: ClinicalTrials.gov record NCT01391624. Inclusion in this directory is not an endorsement.